면역종양학 분석 시장 : 제품별, 기술별, 적응증별, 용도별, 지역별

Immuno-Oncology Assays Market, By Product, By Technology, By Indication, By Application, By Geography

US $ 4,500 ￦ 6,256,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,732,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,903,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

면역종양학 분석 세계 시장은 2025년에는 55억 5,000만 달러, 2032년에는 118억 2,000만 달러에 이르고, 2025-2032년 CAGR 11.4%로 성장할 전망입니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	55억 5,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간(2025-2032년) CAGR	11.40%	2032년 가치 예측	118억 2,000만 달러

면역종양학 분석은 암 면역 요법과 관련된 단백질과 같은 생체 분자의 발현 분석에 도움이 됩니다. 이러한 분석은 종양 프로파일링, 치료 전략, 면역요법 개발에 도움이 됩니다. 면역 바이오마커의 발현을 평가함으로써, 암과 면역의 상호작용에 관한 중요한 지견을 얻을 수 있어 표적 치료의 방향성이 나타납니다. 단백질체학, 유전체 분석 및 멀티플렉스 기술과 같은 분야의 개발은 높은 처리량의 면역종양학 분석의 개발을 가능하게했습니다. 기존의 항종양 면역 반응을 측정하고 치료 결과를 예측하는 이러한 능력은 정밀 종양학에서 필수적인 도구가 되었습니다.

시장 역학 :

세계의 면역종양학 분석 시장의 성장은 표적 암 치료에 대한 수요 증가, 병용 면역 요법의 채용 증가, 제약 기업에 의한 R&D 투자 증가, 동반진단 검사의 가용성 향상 등의 요인에 의해 견인되고 있습니다. 그러나 면역종양학 검사와 관련된 고액의 비용과 이러한 검사에 대한 상환의 제한 등 시장 성장 억제요인도 있습니다. 한편, 바이오마커 연구의 진행과 저렴한 면역종양학적 검사법의 개발은 시장 진출자에게 큰 비즈니스 기회가 되고 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 면역종양학 분석 시장을 상세하게 분석하고, 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
• 다양한 부문에서 잠재적인 수익 성장 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 면역종양학 분석 시장의 주요 기업을 프로파일링합니다.
• 주요 기업은 Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc, QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexe Molecular Diagnostics, Inc., Axion BioSystems, Inc., BioTherapeutics LLC.
• 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• Immuno-on Cologe Assay 세계 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 수용합니다.
• 이해관계자들은 세계의 면역종양학 분석 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금 조달 및 투자
• PEST 분석
• Porter's Five Forces 분석

제4장 세계의 면역종양학 분석 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부의 대처
• COVID-19에 의한 시장에 대한 영향

제5장 세계의 면역종양학 분석 시장, 제품별, 2020년-2032년,(10억 달러)

• 소모품
• 소프트웨어

제6장 세계의 면역종양학 분석 시장, 기술별, 2020년-2032년,(10억 달러)

• 면역 측정
• PCR
• 차세대 시즈
• 플로우 사이토메트리
• 기타

제7장 세계의 면역종양학 분석 시장, 적응증별, 2020년-2032년,(10억 달러)

• 대장암
• 폐암
• 악성 흑색종
• 방광암
• 기타

제8장 세계의 면역종양학 분석 시장, 용도별, 2020년-2032년,(10억 달러)

• 임상 진단
• 연구개발

제9장 세계의 면역종양학 분석 시장, 지역별, 2020년-2032년,(10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제10장 경쟁 구도

• 기업 프로파일
  • Charles River Laboratories
  • F. Hoffmann-La Roche Ltd
  • llumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

제11장 분석가 추천

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제12장 참고문헌과 조사방법

• 참고문헌
• 조사 방법

SHW

영문 목차

영문목차

Global Immuno-Oncology Assays Market is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 11.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.55 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.40%	2032 Value Projection:	USD 11.82 Bn

Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics:

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study:

• This report provides an in-depth analysis of the global immuno-oncology assays market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global immuno-oncology assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market

Detailed Segmentation-

• By Product:
  • Consumables
  • Software
• By Technology:
  • Immunoassay
  • PCR
  • NGS
  • Fow Cytometry
  • Others
• By Indication:
  • Colorectal Cancer
  • Lung Cancer
  • Melanoma
  • Bladder Cancer
  • Others
• By Application:
  • Clinical Diagnostics
  • Research and Development
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Charles River Laboratories
  • Hoffmann-La Roche Ltd
  • llumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Technology
  • Market Snapshot, By Indication
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Immuno-Oncology Assays Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Immuno-Oncology Assays Market, By Technology, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Immunoassay
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• PCR
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• NGS
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fow Cytometry
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Immuno-Oncology Assays Market, By Indication, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Colorectal Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Melanoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bladder Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Immuno-Oncology Assays Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Immuno-Oncology Assays Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Charles River Laboratories*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • llumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact

관련자료